In this study, by depleting RUNX1 in vitro and in vivo, we expose a link between oestrogen and β-catenin in ER+ breast cancer, that is, RUNX1-gated oestrogen-mediated AXIN1 transcriptional repression. The gene discussed is AXIN1; the disease is breast cancer.